Stockreport

Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors [Yahoo! Finance]

Xilio Therapeutics, Inc.  (XLO) 
PDF developing tumor-activated immuno-oncology therapies for people living with cancer, today announced the appointment of Akintunde (Tunde) Bello, Ph.D., to the company's b [Read more]